These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 19901428)
41. The role of human papillomavirus vaccines in cervical neoplasia. Stern PL; Faulkner R; Veranes EC; Davidson EJ Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873 [TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus and cervical disease in adolescents. Guido R Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460 [TBL] [Abstract][Full Text] [Related]
43. Cervical cancer screening & HPV vaccination: a comprehensive approach to cervical cancer control. Basu P; Chowdhury D Indian J Med Res; 2009 Sep; 130(3):241-6. PubMed ID: 19901433 [TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccine: progress and the future. Dinh TA; Benoit MF Expert Opin Biol Ther; 2007 Apr; 7(4):479-85. PubMed ID: 17373899 [TBL] [Abstract][Full Text] [Related]
45. God's gift to women: the human papillomavirus vaccine. Frazer I Immunity; 2006 Aug; 25(2):179-84. PubMed ID: 16920633 [TBL] [Abstract][Full Text] [Related]
46. How to kill a cancer. Gorman C Time; 2002 Dec; 160(23):80. PubMed ID: 12500691 [No Abstract] [Full Text] [Related]
47. Human papillomavirus and cervical cancer. Unger ER; Barr E Emerg Infect Dis; 2004 Nov; 10(11):2031-2. PubMed ID: 16010736 [No Abstract] [Full Text] [Related]
48. HPV vaccines--why aren't they the answer yet? Brown AK; Moore RG Med Health R I; 2005 Mar; 88(3):74-9. PubMed ID: 15915778 [No Abstract] [Full Text] [Related]
49. [Papillomavirus and cancer: new lights]. Nau JY Rev Med Suisse; 2010 Nov; 6(269):2110. PubMed ID: 21140969 [No Abstract] [Full Text] [Related]
51. [Cervix cancer can be prevented. Efficient HPV tests and highly-protective vaccine soon available for clinical use]. Bistoletti P Lakartidningen; 2006 May 3-9; 103(18):1402. PubMed ID: 16729451 [No Abstract] [Full Text] [Related]
52. Human papilloma viruses and cancer in the post-vaccine era. Galani E; Christodoulou C Clin Microbiol Infect; 2009 Nov; 15(11):977-81. PubMed ID: 19874381 [TBL] [Abstract][Full Text] [Related]
54. Judging the carcinogenicity of rare human papillomavirus types. Combes JD; Guan P; Franceschi S; Clifford GM Int J Cancer; 2015 Feb; 136(3):740-2. PubMed ID: 24917192 [No Abstract] [Full Text] [Related]
55. Biochip to detect human papillomavirus in Mexico. Orellana C Lancet Oncol; 2004 Aug; 5(8):465. PubMed ID: 15309780 [No Abstract] [Full Text] [Related]
56. A conversation with Doug Lowy and John Schiller. Neill US J Clin Invest; 2018 Jan; 128(1):1-3. PubMed ID: 29293098 [No Abstract] [Full Text] [Related]
57. Testing urine for cervical human papillomavirus. Yaqub F Lancet Oncol; 2014 Nov; 15(12):e531. PubMed ID: 25602102 [No Abstract] [Full Text] [Related]
58. Spotlight on papillomaviruses. M O Int J Cancer; 2006 Dec; 119(11):ix. PubMed ID: 17058201 [No Abstract] [Full Text] [Related]
59. Eleven questions regarding cervical cancer prevention in India. Suba EJ J Cancer Res Ther; 2014; 10(3):459-60. PubMed ID: 25313722 [No Abstract] [Full Text] [Related]
60. Cervical cancer: advances in prevention and knowledge of its etiology. Bosch FX Salud Publica Mex; 2003; 45 Suppl 3():S297-300. PubMed ID: 14746020 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]